These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1478 related articles for article (PubMed ID: 33828988)
1. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Lin Z; Xu Q; Miao D; Yu F Front Oncol; 2021; 11():644416. PubMed ID: 33828988 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
3. Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer. Wu Z; Zhuang X; Liang M; Sheng L; Huang L; Li Y; Ke Y Front Mol Biosci; 2024; 11():1394902. PubMed ID: 38903179 [No Abstract] [Full Text] [Related]
4. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma. Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899 [TBL] [Abstract][Full Text] [Related]
5. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210 [TBL] [Abstract][Full Text] [Related]
6. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R Front Genet; 2022; 13():907331. PubMed ID: 35938001 [No Abstract] [Full Text] [Related]
10. Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma. Zou W; Chen L; Mao W; Hu S; Liu Y; Hu C Front Bioeng Biotechnol; 2021; 9():772206. PubMed ID: 34881236 [No Abstract] [Full Text] [Related]
11. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma. Chen W; Yang Z; Chen Y Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
13. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients. Lv W; Yao Q Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936 [TBL] [Abstract][Full Text] [Related]
14. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis. Zhu W; Ru L; Ma Z Front Oncol; 2021; 11():626654. PubMed ID: 33777771 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma. Lin Z; Xu Q; Song X; Zeng Y; Zeng L; Zhao L; Xu J; Miao D; Chen Z; Yu F Front Oncol; 2022; 12():748557. PubMed ID: 35311113 [TBL] [Abstract][Full Text] [Related]
18. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Song D; Zhou Z; Zhang D; Wu J; Hao Q; Zhao L; Ren H; Zhang B Front Genet; 2022; 13():850200. PubMed ID: 35711939 [TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Novel Tertiary Lymphoid Structures-Related Prognostic Gene Signature in Hepatocellular Carcinoma. Liu Y; Li CB; Zhai YP; Zhang SK; Li DY; Gao ZQ; Liang RP World J Oncol; 2024 Aug; 15(4):695-710. PubMed ID: 38993245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]